Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Herstel van hand- en armmotor via niet-invasieve elektrische stimulatie van het ruggenmerg na een beroerte (HARNESS)

30 oktober 2026 bijgewerkt door: Chet Moritz, University of Washington

The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.

Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.

The aims of the study are:

  1. to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
  2. to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Geschat)

6

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • Washington
      • Seattle, Washington, Verenigde Staten, 98105
        • Werving
        • University of Washington
        • Onderonderzoeker:
          • Fatma Inanici, MD, PhD
        • Hoofdonderzoeker:
          • Chet T Moritz, PhD
        • Contact:
          • Fatma Inanici, MD, Ph.D.
          • Telefoonnummer: 2067872692
          • E-mail: finanici@uw.edu

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

21 jaar tot 80 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
  • At least six months post-stroke
  • Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
  • Medically and neurologically stable, as determined by medical history and documented physical examination
  • For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
  • Ability to attend sessions three times per week
  • Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
  • Ability to read, comprehend and speak English

Exclusion Criteria:

  • Hemorrhagic stroke
  • History of multiple strokes
  • Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
  • Aphasia or any other deficit in communication that interferes with reasonable study participation
  • Moderate to severe cognitive impairment
  • Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
  • Severe spasticity in the upper limb
  • Taking baclofen more than 30 mg/day
  • Change in baclofen dose within four weeks before enrollment
  • Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
  • Botulinum toxin injection to the upper limb muscles within six months before enrollment
  • Severe joint contractures in the affected hand and arm
  • History of spontaneous seizure that had occurred one month or longer after the stroke

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Crossover-opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Activity Based Rehabilitation

Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

Experimenteel: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation

Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

Electrical stimulation of the spinal cord using surface electrodes

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change from baseline - Fugl-Meyer assessment of the upper limb
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Pinch and grip force
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Measurement of hand strengths using a dynamometry.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Modified Ashworth Scale
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Wolf Motor Function Test
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change from baseline - Action Research Arm Test
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Box and Blocks Test
Tijdsspanne: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Revised Nottingham Sensory Assessment
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Stroke Impact Scale
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Short Form-36
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Patients Global Impression of Change
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - H-reflex test
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Somatosensory evoked potentials test
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of sensory pathways between the brain and the limb.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Spinally evoked motor potentials test
Tijdsspanne: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Chet Moritz, PhD, University of Washington

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 oktober 2022

Primaire voltooiing (Geschat)

31 december 2027

Studie voltooiing (Geschat)

31 december 2027

Studieregistratiedata

Eerst ingediend

13 oktober 2022

Eerst ingediend dat voldeed aan de QC-criteria

18 oktober 2022

Eerst geplaatst (Werkelijk)

24 oktober 2022

Updates van studierecords

Laatste update geplaatst (Werkelijk)

4 november 2026

Laatste update ingediend die voldeed aan QC-criteria

30 oktober 2026

Laatst geverifieerd

1 oktober 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Ja

product vervaardigd in en geëxporteerd uit de V.S.

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren